Clinical trials
Ischemic Stroke trials in Canada with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 8 |
| Active, not recruiting | 4 |
| Unknown status | 4 |
| Not yet recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of British Columbia | 5 |
| Sunnybrook Health Sciences Centre | 4 |
| Unity Health Toronto | 3 |
| Abbott Medical Devices | 2 |
| Josep Rodes-Cabau | 2 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| University of Alberta | 2 |
| 880 Medical, LLC | 1 |
| AtriCure, Inc. | 1 |
| B-Temia, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 39 |
| Stroke | 15 |
| Hemorrhagic Stroke | 7 |
| Atrial Fibrillation | 3 |
| Brain Injuries | 3 |
| Cerebrovascular Disorders | 3 |
| Foramen Ovale, Patent | 3 |
| Brain Diseases | 2 |
| Brain Infarction | 2 |
| Brain Ischemia | 2 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.